Representational photo via iStock

The Department of Health and Social Care (DHSC) has notified pharmacies over the limited stock of Disopyramide 100mg capsules and shortage of Disopyramide 150mg capsules until the end of March 2022.

“Disopyramide 250mg MR tablets remain available and can support an increase in demand,” said DHSC.

Community pharmacies should note that where patients have insufficient supplies to last until the resupply date:

  • Emergency orders can be placed directly with Drugsrus for supply of a limited volume of disopyramide 100mg capsules to cover until the resupply date (see supporting information). Email [email protected] for further information.
  • If this stock is no longer available, pharmacists should refer the patient back to their GP to seek specialist cardiology advice on alternative treatment options.
  • For patients requiring disopyramide 150mg capsules pharmacists should refer the patient back to their GP to seek specialist cardiology advice on alternative treatment options (see supporting information).

The pharmacy negotiator PSNC said: “In all settings patients should be counselled on any new formulation and dose change, and advised to report any adverse effects or recurrence of symptoms.”

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool. To access the Tool you will be required to register with the SPS website.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY